Coagulopathy in a patient with nephrotic syndrome

Am J Hematol. 2010 Sep;85(9):708-10. doi: 10.1002/ajh.21782.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Amyloid / blood
  • Amyloidosis / blood
  • Amyloidosis / diagnosis*
  • Amyloidosis / drug therapy
  • Amyloidosis / pathology
  • Antifibrinolytic Agents / administration & dosage
  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Blood Coagulation / drug effects
  • Blood Coagulation Factors / metabolism
  • Dexamethasone / administration & dosage
  • Disseminated Intravascular Coagulation / blood
  • Disseminated Intravascular Coagulation / diagnosis*
  • Disseminated Intravascular Coagulation / drug therapy
  • Disseminated Intravascular Coagulation / pathology
  • Female
  • Humans
  • Immunoglobulin kappa-Chains / blood
  • International Normalized Ratio
  • Melphalan / administration & dosage
  • Middle Aged
  • Nephrotic Syndrome / blood
  • Nephrotic Syndrome / diagnosis*
  • Nephrotic Syndrome / drug therapy
  • Nephrotic Syndrome / pathology
  • Partial Thromboplastin Time
  • Vitamin K / administration & dosage

Substances

  • Amyloid
  • Antifibrinolytic Agents
  • Antineoplastic Agents, Alkylating
  • Antineoplastic Agents, Hormonal
  • Blood Coagulation Factors
  • Immunoglobulin kappa-Chains
  • Vitamin K
  • Dexamethasone
  • Melphalan